SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending following the release of positive Week 52 Phase 3 trial results, which investors are positioning as a strong best-in-class indicator for their skin drug, sonelokimab. The community is actively debating the potential for an upcoming acquisition and monitoring institutional accumulation, while some retail traders express frustration over recent price volatility and the timeline for further clinical data readouts.

Keel Infrastructure Corp. engages in building artificial intelligence focused data centers and energy assets. It focuses on infrastructure and energy required to support high-performance computing and artificial intelligence workloads. The company was founded on April 1, 2026 and is headquartered in New York, NY.

Keel Infrastructure Corp.

Keel Infrastructure Corp

Keel Infrastructure Corp is trending as investors bet on the company's pivot from crypto mining to high-demand AI and HPC data center infrastructure, fueled by recent FERC grid connectivity mandates and anticipation of upcoming lease contracts. The community is actively discussing the stock's upward momentum, potential Russell 3000 index inclusion, and the impact of institutional positioning on future price action.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is trending due to its aggressive price appreciation fueled by a persistent global memory shortage and robust demand from AI data centers, leaving the community divided between those riding the momentum and others fearing a bubble-driven correction. Investors are intensely focused on memory sector health, with many closely watching upcoming earnings catalysts for signs of continued sector strength or a potential trend reversal.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals is attracting intense community interest as high trading volume and recent insider activity fuel speculation about potential acquisition interest or upcoming strategic catalysts. Investors are actively discussing the impact of new management's positioning, while closely watching key technical levels and patent developments that could signal a breakout for the stock.

Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Definium Therapeutics Inc.

Definium Therapeutics is experiencing a significant surge and high investor interest following the announcement of positive Phase 3 topline results for its DT120 treatment in major depressive disorder. The community is actively debating the company's valuation and long-term potential, with bulls citing robust clinical data and upcoming catalysts, while skeptics focus on concerns regarding cash burn, potential share dilution, and the competitive landscape for psychedelic therapies.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is experiencing significant selling pressure and heightened volatility, as investors weigh concerns over subscriber growth against management's capital allocation and potential M&A activity. The community remains deeply polarized, with bears aggressively betting on further downside following recent technical breaks, while bulls are scouting for value in what they consider an oversold market leader.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is seeing heavy volume and a significant rebound as investors pivot focus from recent dilution concerns toward strong AI infrastructure demand, including a new blueprint for Nvidia's Vera Rubin systems. The stock remains a battleground as the community debates whether the influx of institutional buying signals a long-term bottom or continues to face volatility from retail skepticism.

MP Materials Corp. engages in the production and marketing of rare earth specialty materials. It operates through the following segments: Materials and Magnetics. The Materials segment focuses on the operation of Mountain Pass, which produces refined rare earth oxides and related products, as well as rare earth concentrate products. The Magnetics segment is involved in the operation of Independence Facility, where the company began production of magnetic precursor products. The company was founded by James Henry Litinsky and Michael Rosenthal in 2017 and is headquartered in Las Vegas, NV.

MP Materials Corporation

MP Materials is under intense focus as China implements new export controls and security reviews on critical minerals, prompting community debate over domestic supply chain independence and the effectiveness of existing government partnerships. Investors are closely monitoring how the company handles compliance and competitive pressures while weighing the broader geopolitical implications of restricted dual-use material access for the U.S. defense industrial base.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is trending as investors anticipate the upcoming launch of its Phase 3 clinical trial for NSCLC, which could transform the company into a de-risked multi-asset oncology platform. Community discussion remains heavily focused on potential buyout opportunities, favorable clinical readouts, and the strategic importance of CMC validation as the company nears its BLA submission.

HIVE Digital Technologies Ltd. engages in building a bridge between the digital currency and blockchain sector and traditional capital markets. The firm operates data centers for computing and mining cryptocurrencies, including Bitcoin and other coins. It owns and operates green energy-powered data center facilities in Canada, Sweden, and Iceland. The company was founded on June 24, 1987 and is headquartered in San Antonio, TX.

HIVE Digital Technologies Ltd.

HIVE Digital Technologies Ltd

HIVE Digital Technologies is generating significant investor interest following the validation of its Paraguay AI infrastructure by a Columbia University study and ongoing discussions regarding its strategic expansion into sovereign AI data centers. The community is actively debating the stock's valuation as it pivots from traditional mining to high-performance computing, with many users focusing on the long-term potential of its upcoming data center projects in Canada and Sweden.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

I&#39;m following the footprints on $CVAC—the 10-day VWAP is finally turning into a launchpad. 🏗️⚡ 
 
Setup: Perfect 8h pivot bottom; RSI is waking up from the dead (31) meaning the spring is officially loaded. 
 
Unusual Flow: 13F filings show Citadel and Susquehanna shifting heavily into calls (+136%) as the merger floor solidifies. 🏗️ 
 
Target: Clearing the $4.37 wall triggers the gap-fill to the $6.83 bull targets. 📈 
 
Safety: Stop below the $4.07 structural floor. 🧱 The BioNTech moat is absorbing the competition. Don&#39;t fight the $101.88 exchange reference price. 🚢📉 #hovdid

StockTwits Web

CureVac N.V.

—the 10-day VWAP is finally turning into a launchpad. 🏗️⚡ 
 
Setup: Perfect 8h pivot bottom; RSI is waking up from the dead (31) meaning the spring is officially loaded. 
 
Unusual Flow: 13F filings show Citadel and Susquehanna shifting heavily into calls (+136%) as the merger floor solidifies. 🏗️ 
 
Target: Clearing the $4.37 wall triggers the gap-fill to the $6.83 bull targets. 📈 
 
Safety: Stop below the $4.07 structural floor. 🧱 The BioNTech moat is absorbing the competition. Don't fight the $101.88 exchange reference price. 🚢📉 